Instituto do Cancer do Estado de San Paulo

São Paulo, São Paulo 05403-900

0 studies enrolling now · 1 studies all time

What they study most

Triple Negative Breast Cancer

Studies at this site

• Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC — Running, not enrolling